These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11261810)

  • 1. Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trial.
    Aisen PS
    Acta Neurol Scand Suppl; 2000; 176():85-9. PubMed ID: 11261810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial.
    Aisen PS; Schafer KA; Grundman M; Pfeiffer E; Sano M; Davis KL; Farlow MR; Jin S; Thomas RG; Thal LJ;
    JAMA; 2003 Jun; 289(21):2819-26. PubMed ID: 12783912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study.
    Aisen PS; Davis KL; Berg JD; Schafer K; Campbell K; Thomas RG; Weiner MF; Farlow MR; Sano M; Grundman M; Thal LJ
    Neurology; 2000 Feb; 54(3):588-93. PubMed ID: 10680787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of selective COX-2 inhibitors for the treatment of Alzheimer's disease.
    Aisen PS
    J Pain Symptom Manage; 2002 Apr; 23(4 Suppl):S35-40. PubMed ID: 11992749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-steroidal anti-inflammatory drugs and cyclooxygenase in Alzheimer's disease.
    Hoozemans JJ; Veerhuis R; Rozemuller AJ; Eikelenboom P
    Curr Drug Targets; 2003 Aug; 4(6):461-8. PubMed ID: 12866660
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aspirin, steroidal and non-steroidal anti-inflammatory drugs for the treatment of Alzheimer's disease.
    Jaturapatporn D; Isaac MG; McCleery J; Tabet N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD006378. PubMed ID: 22336816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclooxygenase and inflammation in Alzheimer's disease: experimental approaches and clinical interventions.
    Pasinetti GM
    J Neurosci Res; 1998 Oct; 54(1):1-6. PubMed ID: 9778144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-inflammatory agents in Alzheimer's disease.
    Aisen PS
    Curr Neurol Neurosci Rep; 2002 Sep; 2(5):405-9. PubMed ID: 12169220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rofecoxib: no effect on Alzheimer's disease in a 1-year, randomized, blinded, controlled study.
    Reines SA; Block GA; Morris JC; Liu G; Nessly ML; Lines CR; Norman BA; Baranak CC;
    Neurology; 2004 Jan; 62(1):66-71. PubMed ID: 14718699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of tarenflurbil in mild to moderate Alzheimer's disease: a randomised phase II trial.
    Wilcock GK; Black SE; Hendrix SB; Zavitz KH; Swabb EA; Laughlin MA;
    Lancet Neurol; 2008 Jun; 7(6):483-93. PubMed ID: 18450517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroinflammation in Alzheimer's disease: potential targets for disease-modifying drugs.
    Hüll M; Hampel H
    Ernst Schering Res Found Workshop; 2002; (39):159-78. PubMed ID: 12066411
    [No Abstract]   [Full Text] [Related]  

  • 12. Experimental brain inflammation and neurodegeneration as model of Alzheimer's disease: protective effects of selective COX-2 inhibitors.
    Giovannini MG; Scali C; Prosperi C; Bellucci A; Pepeu G; Casamenti F
    Int J Immunopathol Pharmacol; 2003; 16(2 Suppl):31-40. PubMed ID: 14552702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease and inflammation: a review of cellular and therapeutic mechanisms.
    Halliday G; Robinson SR; Shepherd C; Kril J
    Clin Exp Pharmacol Physiol; 2000; 27(1-2):1-8. PubMed ID: 10696521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclo-oxygenase-2 inhibitors: rationale and therapeutic potential for Alzheimer's disease.
    McGeer PL
    Drugs Aging; 2000 Jul; 17(1):1-11. PubMed ID: 10933512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-inflammatory drugs: a hope for Alzheimer's disease?
    Hüll M; Lieb K; Fiebich BL
    Expert Opin Investig Drugs; 2000 Apr; 9(4):671-83. PubMed ID: 11060701
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of inflammatory reaction in Alzheimer's disease and neurodegenerative processes].
    Członkowska A; Kurkowska-Jastrzebska I
    Neurol Neurochir Pol; 2002; 36(1):15-23. PubMed ID: 12053606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-steroidal anti-inflammatory drugs (NSAIDs) and other anti-inflammatory agents in the treatment of neurodegenerative disease.
    Klegeris A; McGeer PL
    Curr Alzheimer Res; 2005 Jul; 2(3):355-65. PubMed ID: 15974901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-inflammatory therapy in Alzheimer's disease: is hope still alive?
    van Gool WA; Aisen PS; Eikelenboom P
    J Neurol; 2003 Jul; 250(7):788-92. PubMed ID: 12883918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunologic and inflammatory mediators and cognitive decline in Alzheimer's disease.
    Ahluwalia N; Vellas B
    Immunol Allergy Clin North Am; 2003 Feb; 23(1):103-15. PubMed ID: 12645881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammation and Alzheimer disease.
    Aisen PS
    Mol Chem Neuropathol; 1996; 28(1-3):83-8. PubMed ID: 8871945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.